Healthcare >> CEO Interviews >> February 2, 2002
CANDACE KENDLE, Pharm.D., is co-Founder, Chairman and Chief Executive
Officer of Kendle International, Inc., a global provider of clinical
development services for the pharmaceutical and biotechnology
industries. Dr. Kendle has guided the company from a small, private
concern in 1981 into a full-service, publicly held contract research
organization with offices on four continents and more than 1,700
associates worldwide. Dr. Kendle's background in the pharmaceutical
industry includes extensive academic experience. Her many academic
positions have included acting Chairperson and Associate Professor at
the University of North Carolina School of Pharmacy and School of
Medicine, Clinical Associate Professor of Pediatrics at the University
of Pennsylvania School of Medicine, Clinical Assistant Professor at the
Philadelphia College of Pharmacy and Sciences and Adjunct Associate
Professor at the University of Cincinnati School of Pharmacy. She also
served as Director of Pharmacy at The Children's Hospital of
Philadelphia. Dr. Kendle received Doctorate and Bachelor of Science
degrees in Pharmacy from the University of Cincinnati. She completed her
residency at Children's Hospital Medical Center in Cincinnati and an
Epidemiology Fellowship at the University of North Carolina School of
Public Health. Dr. Kendle also has completed continuing education
courses at Harvard Business School and Stanford University. Dr. Kendle
is the recipient of numerous business and community awards. Most
recently, she received the 2001 Arthur C. Glasser Distinguished Alumni
Award from the University of Cincinnati College of Pharmacy .She was a
Finalist in the 1999 National Ernst & Young Entrepreneur of the Year'
awards (healthcare/life sciences category).Dr. Kendle is active in
numerous business and community organizations. She serves as a Director
of the H. J. Heinz Company and the Isabella Venture Fund. Profile
Kendle International?
Ms. Kendle: Kendle was founded in 1981 as a small, private consulting
company in what was at that
